Oxford Biomedica Solutions
David Rouleau is a Research Associate II at Oxford Biomedica since March 2021, specializing in NGS department work and data analysis. Prior experience includes roles as a Process Technician at Pfizer, supporting clinical manufacturing, and as a Lab Assistant at Elkinton Lab, where database creation and data analysis were key responsibilities. David Rouleau also served in various IT support roles at the University of Massachusetts Amherst and worked as a Head Lifeguard for Haverhill Recreation Department, overseeing safety and maintenance. Educationally, David Rouleau holds a Bachelor of Science in Biology from the University of Massachusetts Amherst, obtained in 2020.
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.